Methylphenidate Hydrochloride Tablet, Extended Release
Vertical Pharmaceuticals, LLC · Available
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 07/26/2023
- Package NDC
- 68025-098-30
- Generic name
- Methylphenidate Hydrochloride Tablet, Extended Release
- Contact info
- 800-541-4802
- Availability
- Available
- Update date
- 09/16/2026
- Dosage form
- Tablet
- Presentation
- Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-30)
- Company name
- Vertical Pharmaceuticals, LLC
- Status
- Current
- Therapeutic category
- Psychiatry
- Harmonized identifiers (openFDA)
- Application number
- NDA216117
- Brand name
- RELEXXII
- Generic name
- METHYLPHENIDATE HYDROCHLORIDE
- Manufacturer name
- Vertical Pharmaceuticals, LLC
- Product NDC
- 68025-098, 68025-088, 68025-089, 68025-095, 68025-096, 68025-097, 68025-084
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- METHYLPHENIDATE HYDROCHLORIDE
- RxCUI
- 1091155, 1091170, 1091185, 1091210, 1995461, 2052826, 2605796, 2605798, 2605943, 2605946, 2668496, 2668499, 2668502, 2668505
- SPL ID
- 86f477e9-07fc-466b-913e-1a4434c91df4
- SPL set ID
- 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d
- Package NDC
- 68025-088-30, 68025-089-30, 68025-095-10, 68025-095-30, 68025-096-10, 68025-096-30, 68025-097-10, 68025-097-30, 68025-084-30, 68025-098-10, 68025-098-30
- UNII
- 4B3SC438HI